Indefinite Delivery Contract W912PF06A0032

The National Acquisition Center of the U.S. Department of Veterans Affairs (VA) has awarded a $32,500,000 Blanket Purchase Agreement (BPA) to Ardelyx, Inc., a pharmaceutical company, for the supply of XPHOZAH (tenapanor), a medication used to treat hyperphosphatemia in patients on dialysis. This single-award BPA, which has an ultimate completion date of April 29, 2026, allows VA medical centers nationwide to efficiently procure the XPHOZAH medication as needed through delivery orders. Ardelyx,...

The Department of the Interior US Geological Survey Office of Acquisitions and Grants awarded a single award Blanket Purchase Agreement to Green Eyes LLC on September 20, 2021. The BPA is for soluble reactive phosphorus reagent and standard kits with a potential value of $150,000. The original solicitation was set aside for total small businesses and sought quotes for the same reagent standards, with a posting date of August 12, 2021 and due date of August 27, 2021. The BPA enables the USGS to...

The Defense Health Agency (DHA) awarded a Blanket Purchase Agreement (BPA) to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., for the delivery of PYLARIFY (piflufolastat F-18) injection, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The BPA has a ceiling value of $1,000,000 and a period of performance through January 31, 2028. The contract is not set aside for small businesses. Under this BPA, the DHA...

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to Orphalan LIMITED, a foreign-owned for-profit organization. The contract has a period of performance from June 15, 2024 to June 14, 2029 and a ceiling value of $225,000.00. The contract is for "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under Federal Supply Schedule 65 I B. While the original...

The U.S. Department of Veterans Affairs (VA) has awarded Blanket Purchase Agreements (BPAs) totaling over $4.3 million to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., for the delivery of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used in positron emission tomography (PET) scans to detect prostate cancer. These BPAs, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allow various VA healthcare facilities across the Veterans...

Ardelyx, Inc., a for-profit pharmaceutical company, has been awarded multiple federal contract Indefinite Delivery Vehicles (IDVs) from the U.S. Department of Veterans Affairs (VA) to provide specialized pharmaceutical products, primarily the drug XPHOZAH (tenapanor), to support the healthcare needs of military veterans. The key contracts include a $32,500,000 Blanket Purchase Agreement (BPA) and a $300,000 Federal Supply Schedule (FSS-61-IB) contract, both of which enable Ardelyx to efficiently...

The Department of the Army Materiel Command's Joint Munitions Command (DAMC JMC) awarded a $5,040,000 Indefinite Delivery Contract (IDC) to Icl-Ip America Inc., a foreign-owned for-profit organization, to provide white phosphorus - a key ingredient in certain munitions - in support of the U.S. military's ongoing requirements. The IDC, awarded in March 2020, has a period of performance through March 2025. To date, three firm fixed-price delivery orders have been issued against the IDC, totaling...

This single-award indefinite delivery contract was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The $7.27 million contract, with a performance period ending September 29, 2029, is for the provision of metabolic isotopes to support research studies conducted by various HHS agencies. Pine Pharmaceuticals is an...

The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., for the provision of PYLARIFY (piflufolastat F-18) injection, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The single-award BPA, valued at $2,634,365.60, was established under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has...

The Defense Health Agency (DHA) awarded Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft, a Blanket Purchase Agreement (BPA) contract valued at up to $2,000,000 to provide radiopharmaceuticals and supplies to support nuclear medicine services across various federal healthcare networks. Petnet Solutions is a specialized manufacturer of radioactive tracers and calibration sources used in positron emission tomography (PET) and computed tomography (CT) scans for diagnosing...